Similar findings demonstrating intra-tumor and intra-sample heterogeneity of receptor tyrosine kinase amplification (including HER2, EGFR and FGFR2) expression in gastric cancer, have previously been reported [19-22]. Here, ERBB2 is linked to gastric cancer.